Chapter 2: Drug Testing, Drug Forms, and Drug Measurements

Understanding Pharmacology for Health Professionals: Chapter 2 - Drug Testing, Drug Forms, and Drug Measurements

Learning Objectives

  • 2.1 Describe the process of chemical and animal testing and clinical drug trials.
  • 2.2 Name laws and federal agencies that control drug testing and marketing.
  • 2.3 Name the forms in which drugs are manufactured.
  • 2.4 Describe seven types of tablets and two types of capsules.
  • 2.5 Describe the difference between an ointment, a cream, and a lotion.
  • 2.6 Describe the difference between a solution and a suspension.
  • 2.7 Describe the metric system of drug measurement.
  • 2.8 Describe other drug measurements: units, milliequivalents, percentages, and ratios.
  • 2.9 Demonstrate mastery of the chapter by completing the Chapter Review Exercises.

Drug Testing and Legislation

  • FDA Guidelines: All drugs must undergo rigorous testing by the producing company before they can be marketed, following the protocols established by the FDA.
  • Testing Focus Areas:
    • Effectiveness
    • Safety
  • Process Characteristics:
    • Lengthy and costly, spanning development, testing, manufacturing, and marketing phases.
    • Thousands of chemicals may be evaluated to arrive at one that receives FDA approval.

Chemical and Animal Testing

Types of Testing
  • In Vitro Testing:
    • Meaning: Latin for "in glass".
    • Involves chemical analysis and laboratory tests conducted in test tubes.
  • In Vivo Testing:
    • Meaning: Latin for "in living".
    • Conducted using animal and human subjects.
Animal Testing
  • Purpose: It precedes human testing to evaluate:
    • Side effects
    • Toxic effects
    • Potential addictions
    • Risk of cancerous tumors
    • Possible fetal deformities
    • Pharmacodynamics
  • Pharmacodynamics Definitions:
    • Frequency Distribution Curve: A graphical representation of the number of animals that respond or do not respond to a drug at a specified dose.
    • Half-Life: The duration required for the drug concentration in the blood to decrease from 100% to 50%.
    • Note: This can be extended if liver or kidney function is impaired, affecting the drug's metabolism or excretion.
    • Short half-life necessitates more frequent administration of the drug.
    • Therapeutic Index (TI):
    • Definition: The ratio that represents the margin of safety between a dose that offers therapeutic benefits and one that incurs toxicity. A higher TI signifies a more favorable therapeutic profile.
Investigational New Drug (IND) Application
  • Submission: Sent to the FDA when animal studies conclude and seeks permission for human testing.
  • Contents: Information regarding animal study outcomes, safety data, drug chemistry, and manufacturing processes. If approved, human trials commence.

Clinical Drug Trials

Phase Overview
  • Phase 1:

    • Subjects: Approximately 10 to 100 healthy volunteers.
    • Purpose: Testing safe dosage ranges and side effects. Significant studies include the effect of pharmacokinetics and gender. Duration: about 1.5 years.
  • Phase 2:

    • Subjects: 50 to 500 patients with the targeted disease.
    • Purpose: Experimental administration to determine the therapeutic effect. Duration: typically 2 years.
  • Phase 3:

    • Subjects: Hundreds to thousands of patients, reflecting the real-world use of the drug.
    • Purpose: Comparison to existing treatments and double-blind studies with placebos. Usually lasts 3 years. Includes studies on pediatric dosing.
  • Post-Approval:

    • Following FDA approval via New Drug Application (NDA), ingredients, dosage, and packaging are fixed. Manufacturers can expand drug usage post-approval.
    • Example: Propranolol (Inderal) was initially approved for heart arrhythmias, later for other conditions like hypertension and migraines.

Drug Manufacturing

  • Historical Context: Historically, pharmacists compounded drugs manually; current manufacturing regulations prioritize quality, sanitation, and packaging.
  • Drug Types: Both generic and trade name drugs must have the same active ingredient and dosing but are exempt from similar bioavailability profiles.
  • Packaging: Drugs are sealed in appropriate containers, often with desiccants, to enhance stability and prevent tampering. Individual blister packs protect and identify drug dosage.
  • National Drug Code (NDC): A unique identifier for each drug product is required. Expiration dates are updated for new batches.

Drug Marketing

  • Regulations:
    • Prescription drug advertising is regulated by the FDA.
    • Over-the-counter advertising falls under the jurisdiction of the Federal Trade Commission (FTC).
  • Marketing Strategies:
    • Use of medical journals for advertisement.
    • Distribution of promotional material and direct healthcare provider engagement.
    • Direct-to-consumer (DTC) advertising is prevalent through media channels.
Drug Legislation
  • Historical Laws: Key developments include the Pure Food and Drug Act of 1906, establishing the FDA's authority over approved substance regulation.
  • Drug Patents: Legally protected for 17 years following FDA approval. The exclusive manufacturing and marketing by the original company apply during the patent period, fostering a successful trade name. Upon patent expiration, generics can enter the market. Drugs may acquire multiple trade names based on various manufacturers.

Drug Forms

Manufacturing Forms
  • Drugs can be manufactured in several forms to ensure efficacy and safety. Incorrect administration forms can lead to severe consequences.
  • Examples:
    • Tablets, Capsules, Ointments, Creams, Lotions, Solutions, Suspensions, Powders, Suppositories, Transdermal patches, and Gases.
Types of Tablets
  • General Composition: Each tablet contains the active ingredient plus inert additives for bulk and uniformity.
  • Types Include:
    • Scored: Tablets marked for easy splitting.
    • Effervescent: Designed to dissolve in water for ingestion.
    • Enteric-coated: Withstands stomach acid to dissolve in the small intestine.
    • Caplets: Enteric-coated tablets shaped like capsules, allowing for controlled release.
    • Lozenges: Dissolve in the mouth, releasing medication topically.
    • Troches: Oval tablets that dissolve in the mouth.
Types of Capsules
  • Formulation: Can exist as one-piece gelatin shells (liquid-filled) or two-piece hard shells around powdered or granulated drug forms. Extended-release capsules provide sustained therapeutic effects.

Various Drug Forms Detailing

Liquid Forms
  • Solution: Drug dissolved in a suitable solvent (e.g., sterile water or saline) for injection or oral administration.
  • Suspension: Contains undissolved particles dispersed in a liquid but settles over time; requires shaking.
Other Forms
  • Solid forms like powders, suppositories, or transdermal patches provide diverse administration routes.